title: Transport mechanism of anthracycline derivatives in rat polymorphonuclear leukocytes: uptake and efflux of pirarubicin.
abstract: The characteristics of pirarubicin transport have been investigated in polymorphonuclear leukocytes isolated from rats. The uptake of pirarubicin by leukocytes was time-, temperature- and concentration-dependent with the maximum velocity (Vmax) of 4.84 nmol/5 x 10(6) cells/min and the Michaelis constant (Km) of 13.4 microM. The uptake depended on the extracellular pH, indicating that the molecular form of pirarubicin is more permeable than its ionic form and/or that the transporter of pirarubicin has optimal pH range. When the intracellular space was changed by increasing the medium osmolarity with sucrose, the uptake was altered by osmolarity changes and it appeared that about 27% of the drug was bound to the membrane surface. The initial uptake was inhibited by the metabolic inhibitors rotenone, 2,4-dinitrophenol and sodium cyanide. Pirarubicin accumulation in the intracellular glucose-depleted cells diminished significantly compared with that in normal cells. The efflux of pirarubicin from leukocytes was also temperature-dependent and inhibited by a metabolic inhibitor. These results indicate that a specific mechanism is concerned in the transport of pirarubicin in polymorphonuclear leukocytes.
authors.affiliation: Department of Hospital Pharmacy, Kyoto Pharmaceutical University, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Nagasawa
authors.forename: M
authors.initials: M
authors.lastname: Nomiyama
authors.forename: N
authors.initials: N
authors.lastname: Ohnishi
authors.forename: T
authors.initials: T
authors.lastname: Yokoyama
authors.forename: S
authors.initials: S
authors.lastname: Iwakawa
authors.forename: K
authors.initials: K
authors.lastname: Okumura
mesh_terms: D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000493:pharmacokinetics*; D000963:Antimetabolites / Q000494:pharmacology; D004317:Doxorubicin / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D005947:Glucose / Q000502:physiology; D006863:Hydrogen-Ion Concentration; D066298:In Vitro Techniques; D008297:Male; D009504:Neutrophils / Q000187:drug effects / Q000378:metabolism*; D009994:Osmolar Concentration; D051381:Rats; D017208:Rats, Wistar; D013696:Temperature
chemical_list: D000903:Antibiotics, Antineoplastic; D000963:Antimetabolites; D004317:Doxorubicin; C027260:pirarubicin; D005947:Glucose